chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sweats, pressure in lower right arm and hand keeps going to sleep.  Lots of pressure. Heart palpitations, headache, diarrhea, back aching from 11:30pm 1/23/09 to now 10:55am 10/24/2009
No further AE reported.; Inadvertently administrated a third dose on 02-MAR-2022; previously received doses of GARDASIL 9 on 07AUG2017 and 21AUG2018. inadvertently administered a third dose on; This spontaneous report was received from a nurse referring to a 15-year-old patient with unknown gender. The patient's concurrent condition, pertinent medical history, concomitant medication, drug reactions or allergies were not reported.  On 07-AUG-2017, the patient vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (exact dose, strength, lot #, expiry date, and route of administration were not provided) for prophylaxis. On 21-AUG-2018, the patient vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (exact dose, strength, lot #, expiry date, and route of administration were not provided) for prophylaxis (Inappropriate schedule of vaccine administered).   On 02-MAR-2022, the patient was inadvertently administered a third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (0.5 ml, lot # reported as U036444, expiry date reported as 09-APR-2023, (Lot number U036444 was not valid for hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and does not match any company product as confirmed by Lot Verification team), strength and route of administration were not provided) for prophylaxis (Extra dose administered). No additional adverse event reported.
On 02/07/2022 Patient was administered 0.25 ml Moderna booster that was in fridge for 33 days which is over 30 days recommended. I emailed Moderna about it and was notified that The vaccine administered on February 7, 2022 from lot number 033H21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. No repeat dose is needed.
Myo-pericarditis, diffuse ST elevations and elevated troponins. Left heart cath showed no evident coronary disease.
Extreme joint pain and body aches Joints feel swollen and stiff. Burning and sharp pains in all joints- including fingers and toes
Pfizer-BioNTech COVID-19 Vaccine EUA. Expected adverse effect of sore arm was experienced March 30th, 2021 a couple of hours after injection. Chills experienced around 17:00-19:00 on March 30th, 2021. Sore arm continued from March 30th, 2021 to March 31s, 2021. Chest pain on both sides of front and back experienced on April 1st, 2021 starting around 02:00 until about 05:00. Chest pain can be described as tightness and two sharp pain sources inside the chest one in each chest side. The chest pain woke me up from sleep. Oxymeter shows normal 94-95%, heart beats at 89-110 bpm. It was enough pain to consider taking two Advils, but took one instead just in case I was having a heart attack. I have never experienced chest tightness or pain like that before. Pain slowly subsided after taking one Advil.
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2009, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), for routine adult health maintenance and the intended purpose for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. The patient was diagnosed with shingles after being inoculated with the ZOSTAVAX and suffered serious physical, emotional, and economic damages as a result of the shingles and associated injuries. On an unknown date in 2016, the patient was treated for symptoms of a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
None. Patient got an expired Pfizer covid -19,  Lot expired 12-31-2022 but was given  01/03/2023.
Shortness of breath; This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
101 temp, achy body, 3" x 5" area red and warm to touch. Pt didn't report to us until 10/27/03.
Pt called on 10/5 in the morning complaining of red rash on her arm below the site of injections, arm was swollen to the elbow and difficult to move. Advised pt to see MD - she was seen and MD thought the condition was an infection and prescribed KEFLEX. She is to return to MD on 10/10/2011.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On 2nd May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On 2nd May 2018, less than a day after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced pain in arm and injected limb mobility decreased. On 2nd December 2018, the patient experienced product supply issue. On an unknown date, the outcome of the pain in arm and product supply issue were unknown and the outcome of the injected limb mobility decreased was recovered/resolved. It was unknown if the reporter considered the pain in arm and injected limb mobility decreased to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the deltoid and has been unable to find the 2nd dose since that time. She was given the vaccine high on her arm but could not say if it was in the deltoid area but was close to the bone the and not in the meaty area. She felt this might have been why her arm was so sore, she could not raise it for 4 days. Because the patient could not say it was given outside of the deltoid region, it was not listed as an adverse event. The reporter gave consent to follow up.
Pt recvd series of 3 hep B vax on 0, 1, 6 months schedule.6 mos dose given 17APR90.Pt did not seroconvert.
herpes; This is a spontaneous report from a contactable consumer (patient). A 61-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in arm on an unspecified date as single for COVID-19 immunization. The patient's medical history included developed herpes in 1978 although patient had developed resistance thru out the years and outbreaks were once in a while and basically mild after the shot outbreaks have been constant almost like patient body's attention has been diverted to fight this virus. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Apr2021 15:00 the patient experienced herpes. The event was reported as non-serious. The outcome of the event was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Severe pain; This is a spontaneous report from a contactable physician via Pfizer sales representative.   A patient of unspecified age and gender received meningococcal group b rlp2086 (TRUMENBA) at single dose on unknown date for immunization. On the same date the patient also received meningococcal vaccine B (MENB). Relevant medical history and concomitant medications were not reported. On unknown date the patient experienced severe pain. The outcome of the event was unknown.
Injection site reaction. Pain, redness, swelling around injection area.  A little swelling under the arm in lymph nodes
Information has been received from Bachelor of Science in Nursing concerning a 26 year old female patient with pertinent medical history reported as none and drug reactions or allergies reported as none who on 02-JUL-2009 was vaccinated with a first dose of GARDASIL (lot # -0455Y) 0.5ml, intramuscularly. Concomitant therapy included DEPO-PROVERA. On 02-JUL-2009 after received the vaccine the patient developed persistent arm pain. Patient found taking ibuprofen provided some minor relief. The patient sought medical attention office visit. At the time on the report on 22-JUL-2009 the patient had not recovered. There were no laboratory diagnostics studies performed. Additional information has been requested.
GENERAL ACHE; MISERABLE; SORE ARM; FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 03-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On SEP-2021, the patient experienced general ache. On SEP-2021, the patient experienced miserable. On SEP-2021, the patient experienced sore arm. On SEP-2021, the patient experienced fever. Laboratory data included: Body temperature (NR: not provided) 103 F. The action taken with covid-19 vaccine was not applicable. The outcome of the fever, sore arm, general ache and miserable was not reported. This report was non-serious. This case, from the same reporter is linked to 20210908676, 20210908685 and 20210908729.
This spontaneous report as received from a pharmacist refers to a 60 years old female patient. The patient's medical history included seizures. Concomitant therapies included LEVAQUIN. None drug reactions/allergies were reported. On 01-JUL-2015, the patient was vaccinated with a dose of ZOSTAVAX (o.65 ml, subcutaneously lot # K018173, expiration date 10-JAN-2016). On 02-JUL-2015, the patient developed bronchitis and the flu. The patient sought an unspecified type of medical attention and she received the treatment with M-CLEAR and Z-PAK. None lab diagnostics studies were performed. The outcome of bronchitis and flue was reported as recovered on an unknown date in 2015. The relatedness between the adverse events and the vaccination with ZOSTAVAX was not reported. Additional information has been requested.
I have trouble breathing when I work hard. I get sick all the time, mostly chest colds that won't go away with out medical attention. I have constant joint pain. I forget alot of things that I needed to do or have. It is very frustrating. I have spring and fall allergies, that I never had before. 3/21/06 Received medical records from PCP which reveal patient seen only one time & diagnosed with bronchitis in January, 2006.
Vaccine that administered beyond use date after the thaw process; Vaccine number 2nd and dose volume 0.25; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) and ACCIDENTAL UNDERDOSE (Vaccine number 2nd and dose volume 0.25) in a 24-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 030h21b) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (Intramuscular) .25 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) and ACCIDENTAL UNDERDOSE (Vaccine number 2nd and dose volume 0.25). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process) and ACCIDENTAL UNDERDOSE (Vaccine number 2nd and dose volume 0.25) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 24 years and 04 months. No concomitant medications were reported. On 10-Jun-2022, the vaccine facility staff was notified of an audit that was done and they were made aware of vaccines that were administered beyond use date after the thaw process. Patient had not reported any adverse reactions after the administration of the vaccine. No treatment medications were reported.
Felt burning sensation in left pinky finger while driving on hwy. then numbness in both hands and legs . Then going to a shock not feeling my body and weakness in jaw and loss of motor skills, like paralysis, not able to walk or speak. Loss of speech for about 90 minutes.
Headache, bodyaches, fatigue, nasal congestion, post nasal drip, enlarged/tender axillary and cervical lymph node, neck feels stiff and sore, scattered pustules- 2 on shoulder, one on back and one on left leg.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/21/20 2nd dose01/08/21 Diagnosed covid positive:08/20/21 Symptom onset: Exposure: Symptoms:Asymptomatic
On 5/23/01, mother called office and said that child had hives on upper body and itching. No SOB. Recommended she call MD if SOB or call 911. Benadryl 1 tsp given at home. Seem MD at 13:00 and more Benadryl given. MD thought it was from the MMR.
Patient was diagnosed with multiple sclerosis following a hospitalization from a fall in May 2023. She reported that she had a COVID vaccination on 09/09/2021 and feels that since that time, her MS symptoms overall have been more prevalent. About a year later she had a loss of awareness when showering and was on the floor when she came to. She also advised that she has a constant sensation of an arm band on her left arm where the immunization was administered which has not resolved since the immunization. No other information provided by the patient. Specific vaccination not provided. No other information can be communicated by reporter to VAERS related to this event as details are not available beyond what is being reported.
Arm ended up being itchy with 3 bumps looking like hives. Now arm is red, itchy and hot to touch feeling like a hard lump around the vaccine site. I did take pictures I can email if  you would need to see.
Symptoms began about 8:00 pm: "screaming" headache (9 of 10)- throbbing, poss. pressure behind eyes/ migraine (personal and family history of migraine present), chills, fever (unmeasured), muscle weakness, nausea (no episodes of emesis). Tylenol give 9:00 pm, helped a bit, but not resolving headache. Tylenol at 4:00 am for fever, Tylenol at 11:00 am (next morning), 2 of 10 headache at 1:45 pm next day, but symptoms not entirely resolved according to mother. NOTE: MENVEO given at approximately 2:00 pm at clinic after departing immunization clinic (due to unavailability of the vaccine on site) July 24, 2017.
1/23 vaccination  By that night, it was very sore at injection site. I felt instant pain. It was sore, little bit of pain for hour or so. Closer to end of the night, my arm started to feel 'heavy'. I remember going to sleep, waking up 2 hours later, and my arm was completely numb. As I woke up several times due to bladder, my arm was numb no matter what sleeping position. This lasted, the pain, for 4 days. The numbness was ongoing, non stop, didn't matter if at rest or movement. I decided to go to the Urgent Care near my home. Told me that it would subside. Checked vitals, full body check up. Didn't see anything wrong.  *I have very bad healthcare with the system.  *It has got better that it isn't constant but it is still numb most days. I try to do exercises to alleviate.  *Second pregnancy, EDD 06/26/2021
FATIGUE(TIREDNESS); PAIN AT INJECTION SITE/ARM; NAUSEA; FEVER/CHILLS,FEVER OF 100.8F; SEVERE HEADACHE; FEELS BLOATED WITH ABDOMINAL DISTENTION; SHAKING/TREMBLING; FEELING COLD; FEELING SICK ,UNWELL,DID NOT FEEL WELL, GENERAL MALAISE; VOMITING,RETCHING; ARM WAS VERY PAINFUL; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight was 120 pounds, and height was 65 inches. The patient's concurrent conditions included: occasional migraines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 14-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On AUG-2021, the patient experienced arm was very painful. On 14-AUG-2021, the patient experienced feels bloated with abdominal distention. On 14-AUG-2021, the patient experienced shaking/trembling. On 14-AUG-2021, the patient experienced feeling cold. On 14-AUG-2021, the patient experienced feeling sick, unwell, did not feel well, general malaise. On 14-AUG-2021, the patient experienced vomiting, retching. On 14-AUG-2021, the patient experienced nausea. On 14-AUG-2021, the patient experienced fever/chills, fever of 100.8f. On 14-AUG-2021, the patient experienced severe headache. On 14-AUG-2021, the patient experienced pain at injection site/arm. Laboratory data included: Body temperature (NR: not provided) 100.8 F. On 15-AUG-2021, the patient experienced fatigue (tiredness). Treatment medications (dates unspecified) included: naproxen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shaking/trembling, feeling cold, vomiting,retching, nausea, fever/chills,fever of 100.8f, and severe headache on 15-AUG-2021, and arm was very painful, and pain at injection site/arm on AUG-2021, and had not recovered from fatigue(tiredness), feeling sick ,unwell,did not feel well, general malaise, and feels bloated with abdominal distention. This report was non-serious.
Tested positive for covid; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for covid) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no relevant concomitant medications was reported. No treatment information was provided
Within one minute of vaccination; patient turned pale and fainted in chair and then was gently placed on ground. She returned to consciousness within 5-10 seconds (didn't recall what had happened) and had no other adverse events. water and snack were given to patient.
Nerve damage to hands, legs; Unable to walk; Allergic reaction to anthrax shot; On 26SEP2021, a spontaneous report was received from a company representative who provided information discovered on a social media website.   The reporter provided a video found on an online social media source which discussed a female of an unknown age that received BioThrax (anthrax vaccine adsorbed) on an unknown date and experienced an allergic reaction to the anthrax shot (PT: Drug hypersensitivity) causing disability due to nerve damage to her hands and legs (PT: Nerve injury) and an inability to walk (PT: Gait inability). The patient is seen on the video as being in a wheelchair. The reporter attributes the patient's allergic reaction, nerve damage, inability to walk and resulting disability as related to the anthrax shot. The outcome of the events were not reported.  The patient's medical history and concomitant medication use was not reported.   No additional information was available.  Company Comment:  The Company considers that it is possible that the patient had an allergic reaction as hypersensitivity as it is a known phenomenon that could occur with BioThrax; therefore assessed as "Possible". The assumption that the allergic reaction caused nerve damage to the legs and hands so severe that caused permanent disability is not possible to assess or confirm. It is not know that an allergic reaction could cause neuropathy and although other form of neuropathy like Bell's palsy, has been attributed to COVID 19 and influenza vaccine, it has not been associated to BioThrax nor general neuropathy; therefore, the nerve damage and the inability to walk are considered "Unassessable". More information will be sought.; Sender's Comments: The Company considers that it is possible that the patient had an allergic reaction as hypersensitivity as it is a known phenomenon that could occur with BioThrax; therefore assessed as "Possible". The assumption that the allergic reaction caused nerve damage to the legs and hands so severe that caused permanent disability is not possible to assess or confirm. It is not know that an allergic reaction could cause neuropathy and although other form of neuropathy like Bell's palsy, has been attributed to COVID 19 and influenza vaccine, it has not been associated to BioThrax nor general neuropathy; therefore, the nerve damage and the inability to walk are considered "Unassessable". More information will be sought.